Standout Papers
Immediate Impact
1 by Nobel laureates 1 from Science/Nature 58 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Canhua Jiang being referenced
Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
2024
Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Canhua Jiang | 205 | 401 | 166 | 225 | 93 | 1.1k | |
| Jun Murakami | 219 | 481 | 294 | 186 | 75 | 1.3k | |
| Masao NAGUMO | 131 | 379 | 252 | 165 | 86 | 1.2k | |
| Dipak Sapkota | 98 | 466 | 202 | 230 | 58 | 1.2k | |
| Ieyoshi Kobayashi | 171 | 451 | 277 | 128 | 52 | 1.1k | |
| Hotaka Kawai | 206 | 409 | 210 | 163 | 90 | 1.2k | |
| Qingxuan Wang | 94 | 559 | 137 | 185 | 53 | 1.3k | |
| Kazuo Ryoke | 159 | 393 | 337 | 177 | 64 | 972 | |
| Xiaoshan Wu | 205 | 536 | 63 | 108 | 77 | 1.2k | |
| Frederico O. Gleber‐Netto | 220 | 294 | 280 | 125 | 50 | 930 | |
| Feifei Sun | 74 | 500 | 181 | 251 | 101 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...